Société Deciphera Pharmaceuticals, Inc.
Actions
DCPH
US24344T1016
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
25,36 USD | +0,36% | +72,87% | +57,22% |
30/04 | DECIPHERA PHARMACEUTICALS, INC. : Leerink Partners abaisse son opinion à neutre | ZM |
30/04 | DECIPHERA PHARMACEUTICALS, INC. : JMP Securities n'est plus vendeur | ZM |
Métier
Nombre d'employés: 355
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Switch Control Kinase Inhibitor Platform
100,0
%
| 126 | 100,0 % | 159 | 100,0 % | +26,75% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
76,4
%
| 97 | 77,5 % | 122 | 76,4 % | +25,03% |
Rest of World
12,3
%
| 14 | 11,1 % | 20 | 12,3 % | +39,91% |
Germany
11,3
%
| 14 | 11,4 % | 18 | 11,3 % | +25,58% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17/05/18 |
Tucker Kelly
DFI | Director of Finance/CFO | 53 | 01/02/15 |
Kevin Brodbeck
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/23 |
Chief Tech/Sci/R&D Officer | - | 01/01/17 | |
Dashyant Dhanak
CTO | Chief Tech/Sci/R&D Officer | 63 | 05/09/23 |
Matthew Sherman
CTO | Chief Tech/Sci/R&D Officer | 68 | 02/10/19 |
Lisa Amaya Price
HRO | Human Resources Officer | - | 01/01/22 |
Kelley Dealhoy
PRN | Corporate Officer/Principal | - | 16/06/22 |
Jama Pitman
PRN | Corporate Officer/Principal | 45 | 01/01/15 |
Daniel Martin
PRN | Corporate Officer/Principal | 49 | 18/09/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Patricia Allen
BRD | Director/Board Member | 62 | 01/09/16 |
Edward Benz
BRD | Director/Board Member | 78 | 01/07/19 |
Ron Squarer
CHM | Chairman | 57 | 04/12/19 |
John R. Martin
BRD | Director/Board Member | 63 | 01/02/15 |
James Bristol
BRD | Director/Board Member | 77 | 01/08/07 |
Susan Kelley
BRD | Director/Board Member | 69 | 08/07/19 |
Steven Hoerter
CEO | Chief Executive Officer | 53 | 17/05/18 |
Dennis Walsh
BRD | Director/Board Member | 56 | 01/02/15 |
Director/Board Member | 66 | 01/11/19 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 82 225 972 | 57 541 331 ( 69,98 %) | 0 | 69,98 % |
Coordonnées société
Secteur
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+57,22% | 2,08 Md | |
-1,17% | 102 Md | |
+2,87% | 96,09 Md | |
+2,13% | 22,28 Md | |
-14,77% | 21,4 Md | |
-8,79% | 18,14 Md | |
-39,98% | 17,02 Md | |
-13,21% | 16,09 Md | |
+8,55% | 13,83 Md | |
+35,75% | 11,97 Md |
- Bourse
- Actions
- Action DCPH
- Société Deciphera Pharmaceuticals, Inc.